BTAX (Biostax) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Biostax Days Payable?

Biostax's average Accounts Payable for the three months ended in Jun. 2024 was $1.30 Mil. Biostax's Cost of Goods Sold for the three months ended in Jun. 2024 was $0.00 Mil.

The historical rank and industry rank for Biostax's Days Payable or its related term are showing as below:

During the past 12 years, Biostax's highest Days Payable was 16672.14. The lowest was 16672.14. And the median was 16672.14.

BTAX's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 123.06
* Ranked among companies with meaningful Days Payable only.

Biostax's Days Payable stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00). stayed the same

Biostax Days Payable Historical Data

The historical data trend for Biostax's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biostax Days Payable Chart

Biostax Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

Biostax Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Biostax's Days Payable

For the Biotechnology subindustry, Biostax's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biostax's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biostax's Days Payable distribution charts can be found below:

* The bar in red indicates where Biostax's Days Payable falls into.

Biostax Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Biostax's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (1.3	+	1.214)	/	2 )	/	0	*	365
=	1.257					/	0	*	365
=	N/A

Biostax's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2024 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (1.352	+	1.256)	/	2 )	/	0	*	365 / 4
=	1.304					/	0	*	365 / 4
=	N/A

Biostax Days Payable Related Terms

Thank you for viewing the detailed overview of Biostax's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Biostax Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biostax Corp (OTCPK:BTAX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

2431 Aloma Avenue, Suite 124, Winter Park, FL, USA, 32792

Website

https://www.biostaxcorp.com

Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.

Executives

Glen A Farmer	officer: Chief Financial Officer	20358 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
H. Louis Salomonsky Jr. Revocable Trust	10 percent owner	2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Henry Louis Salomonsky	director, 10 percent owner	2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Kelly O'brien Wilson	10 percent owner, officer: COO and ICEO and IP	2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
James Norman Curley	other: Member of 10% owner group	410 DAHLIA AVE, CORONA DEL MAR CA 92625
Empower Insurance Corp Ltd	other: Member of 10% owner group	1254 LEEWARD HIGHWAY, 4 CARIBBEAN PLACE, PROVIDENCIALES W7 TKCA1ZZ
Global Reverb Corp	10 percent owner, other: Member of 10% owner group	100 S EOLA DR, UNIT 1703, ORLANDO FL 32801
Paul Puskadi	other: Member of 10% owner group	2020 TIGERTAIL BLVD, 7A, DANIA BEACH FL 33004
Deane Rhodes	other: Member of 10% owner group	9200 HALSEY CIRCLE NE, TUSCALOOSA AL 35406
Roger Dale Bozarth	other: Member of 10% owner group	9028 GREAT HERON CIR, ORLANDO FL 32836
Joel Yanowitz	other: Member of 10% owner group	100 TAMAL PLZ, SUITE 106, CORTE MADERA CA 94925
Rogoff Family Trust Dtd	other: Member of 10% owner group	20701 N SCOTTSDALE DR, ST 107-501, SCOTTSDALE AZ 85255
George Sasko	other: Member of 10% owner group	515 WESTCHESTER DR, STE D, CAMPBELL CA 95008
Raster Investments, Inc	other: Member of 10% owner group	2384 ORCHARD CREST BLVD, MANASQUAN NJ 08736
Robert Jackman Dailey	other: Member of 10% owner group	401 FIRST STREET, LOS ALTOS CA 94022